Trial Profile
A Phase I/IIa Study of Decitabine in Combination With Genistein in Pediatric Patients With Relapsed or Refractory Solid Tumors and Leukemia
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 20 Nov 2017
Price :
$35
*
At a glance
- Drugs Decitabine (Primary) ; Genistein (Primary)
- Indications Leukaemia; Lymphoma; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 14 Nov 2017 Status changed from recruiting to completed.
- 22 Jul 2015 New trial record